ONTOLOGY REPORT - ANNOTATIONS
| Term: | quercetin |
|
| Accession: | CHEBI:16243
|
browse the term
|
| Definition: | A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. |
| Synonyms: | exact_synonym: | 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one |
| | related_synonym: | 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 3,5,7,3',4'-PENTAHYDROXYFLAVONE; C15H10O7; InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H; InChIKey=REFJWTPEDVJJIY-UHFFFAOYSA-N; Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O; sophoretin; xanthaurine |
| | alt_id: | CHEBI:11704; CHEBI:14991; CHEBI:26472; CHEBI:45280; CHEBI:8696 |
| | xref_casrn: | 117-39-5 |
| | xref: | Beilstein:317313 "Beilstein Registry Number"; ChEMBL:103666 "ChEMBL COMPOUND"; ChemIDplus:117-39-5 "CAS Registry Number"; CiteXplore:18549926 "PubMed citation"; CiteXplore:18564899 "PubMed citation"; CiteXplore:18579649 "PubMed citation"; CiteXplore:22920589 "PubMed citation"; CiteXplore:23342112 "PubMed citation"; CiteXplore:23359794 "PubMed citation"; DrugBank:DB04216 "DrugBank"; Gmelin:579210 "Gmelin Registry Number"; HMDB:HMDB05794 "HMDB"; KEGG COMPOUND:117-39-5 "CAS Registry Number"; KEGG COMPOUND:C00389 "KEGG COMPOUND"; LIPID MAPS:LMPK12110004 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D011794 |
| | xref: | MetaCyc:CPD-520 "MetaCyc"; PDBeChem:QUE "PDBeChem"; Patent:KR20120121684 "Patent"; Patent:US2013012577 "Patent"; Reaxys:317313 "Reaxys Registry Number"; Wikipedia:Quercetin "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:57694 |
|
|
quercetin
|
| G |
2010015L04Rik |
RIKEN cDNA 2010015L04 gene |
|
decreases expression |
ISO |
4 |
154,783,299 |
154,817,219 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions |
ISO |
4 |
53,043,661 |
53,172,767 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases abundance |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases transport |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
increases response to substance |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
decreases activity |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
increases expression |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
decreases response to substance |
ISO |
14 |
118,881,914 |
119,105,441 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
14 |
118,881,914 |
119,105,441 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
14 |
118,881,914 |
119,105,441 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
decreases expression |
ISO |
14 |
118,881,914 |
119,105,441 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
decreases response to substance |
ISO |
16 |
20,331,376 |
20,426,467 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
multiple interactions |
ISO |
16 |
20,331,376 |
20,426,467 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
multiple interactions |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
increases expression |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
decreases expression |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
affects export |
EXP |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
affects export |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
decreases expression |
EXP |
9 |
119,250,412 |
119,259,413 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
|
increases phosphorylation |
ISO |
11 |
84,008,940 |
84,215,153 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-Coenzyme A dehydrogenase, very long chain |
|
increases expression |
ISO |
11 |
69,823,694 |
69,828,909 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
ISO |
11 |
105,829,261 |
105,851,259 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
ISO |
11 |
105,829,261 |
105,851,259 |
RGD:6480464 |
CTD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
multiple interactions |
ISO |
X |
160,577,274 |
160,626,350 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
decreases activity |
EXP |
11 |
100,337,670 |
100,389,215 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
decreases expression |
EXP |
11 |
100,337,670 |
100,389,215 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1 |
|
increases expression |
ISO |
4 |
40,090,298 |
40,146,042 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
|
increases expression |
EXP |
14 |
9,058,025 |
9,091,533 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
decreases expression |
ISO |
9 |
104,190,570 |
104,240,052 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
decreases expression |
ISO |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
ISO |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
multiple interactions |
ISO |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
increases expression |
ISO |
2 |
113,873,025 |
113,878,547 |
RGD:6480464 |
CTD |
| G |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
|
increases expression |
ISO |
7 |
141,074,882 |
141,416,780 |
RGD:6480464 |
CTD |
| G |
Adam15 |
a disintegrin and metallopeptidase domain 15 (metargidin) |
|
decreases expression |
ISO |
3 |
89,143,562 |
89,153,932 |
RGD:6480464 |
CTD |
| G |
Adrm1 |
adhesion regulating molecule 1 |
|
decreases expression |
ISO |
2 |
179,906,293 |
179,910,988 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
ISO |
17 |
34,734,807 |
34,737,877 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
decreases expression |
ISO |
13 |
30,428,225 |
30,474,736 |
RGD:6480464 |
CTD |
| G |
Agxt |
alanine-glyoxylate aminotransferase |
|
increases expression |
EXP |
1 |
95,031,853 |
95,041,998 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
affects response to substance |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
affects activity |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
decreases activity |
ISO |
11 |
70,054,957 |
70,068,843 |
RGD:6480464 |
CTD |
| G |
Alpi |
alkaline phosphatase, intestinal |
|
multiple interactions |
ISO |
1 |
88,994,579 |
88,998,181 |
RGD:6480464 |
CTD |
| G |
Ampd2 |
adenosine monophosphate deaminase 2 |
|
decreases expression |
ISO |
3 |
107,876,980 |
107,889,545 |
RGD:6480464 |
CTD |
| G |
Ank |
progressive ankylosis |
|
increases expression |
ISO |
15 |
27,396,432 |
27,524,664 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
multiple interactions |
ISO |
7 |
86,966,689 |
86,987,238 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases expression |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
decreases expression |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
3 |
36,347,845 |
36,374,809 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
affects expression |
ISO |
14 |
34,899,176 |
34,913,757 |
RGD:6480464 |
CTD |
| G |
Aoc3 |
amine oxidase, copper containing 3 |
|
decreases expression |
ISO |
11 |
101,191,920 |
101,200,744 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
decreases expression |
ISO |
10 |
90,452,056 |
90,545,488 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatosis polyposis coli |
|
increases expression |
ISO |
18 |
34,380,638 |
34,481,844 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
affects expression |
ISO |
X |
45,378,323 |
45,388,029 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
12 |
7,984,483 |
8,023,645 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
12 |
7,984,483 |
8,023,645 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases secretion |
ISO |
12 |
7,984,483 |
8,023,645 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
EXP |
7 |
20,281,593 |
20,284,515 |
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
multiple interactions |
ISO |
17 |
35,265,942 |
35,268,697 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
16 |
84,954,688 |
85,173,948 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
16 |
84,954,688 |
85,173,948 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
multiple interactions |
ISO |
4 |
41,039,757 |
41,045,216 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases activity |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Arf3 |
ADP-ribosylation factor 3 |
|
increases expression |
ISO |
15 |
98,568,057 |
98,593,549 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
EXP |
10 |
24,635,013 |
24,647,276 |
RGD:6480464 |
CTD |
| G |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
|
multiple interactions |
ISO |
6 |
136,872,230 |
136,890,238 |
RGD:6480464 |
CTD |
| G |
Arvcf |
armadillo repeat gene deleted in velo-cardio-facial syndrome |
|
decreases expression |
ISO |
16 |
18,348,367 |
18,407,169 |
RGD:6480464 |
CTD |
| G |
Asb16 |
ankyrin repeat and SOCS box-containing 16 |
|
decreases expression |
ISO |
11 |
102,130,137 |
102,139,375 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
increases expression |
EXP |
5 |
130,487,373 |
130,500,201 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
1 |
192,994,175 |
193,007,212 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated homolog (human) |
|
affects response to substance |
EXP |
9 |
53,245,227 |
53,344,776 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2 |
|
decreases expression |
ISO |
5 |
145,944,575 |
145,952,461 |
RGD:6480464 |
CTD |
| G |
Atp6v0b |
ATPase, H+ transporting, lysosomal V0 subunit B |
|
decreases expression |
ISO |
4 |
117,556,935 |
117,559,934 |
RGD:6480464 |
CTD |
| G |
Atp6v1c1 |
ATPase, H+ transporting, lysosomal V1 subunit C1 |
|
decreases expression |
ISO |
15 |
38,591,659 |
38,622,199 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
multiple interactions |
ISO |
11 |
68,859,145 |
68,865,164 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
ISO |
17 |
27,156,757 |
27,165,571 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
EXP |
17 |
27,156,757 |
27,165,571 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
affects expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
EXP |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
affects expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases phosphorylation |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
decreases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l14 |
BCL2-like 14 (apoptosis facilitator) |
|
multiple interactions |
ISO |
6 |
134,346,347 |
134,388,742 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases expression |
ISO |
10 |
74,523,641 |
74,647,668 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma carboxyglutamate protein |
|
decreases expression |
ISO |
3 |
88,187,417 |
88,188,386 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma carboxyglutamate protein |
|
decreases expression |
ISO |
3 |
88,187,417 |
88,188,386 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
decreases expression |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
increases expression |
EXP |
X |
70,728,974 |
70,741,275 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
decreases expression |
ISO |
6 |
108,610,623 |
108,616,919 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine methyltransferase |
|
increases expression |
EXP |
13 |
94,386,846 |
94,407,713 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
affects expression |
ISO |
7 |
28,232,997 |
28,251,000 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
increases expression |
ISO |
14 |
70,874,362 |
70,920,067 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
2 |
133,378,935 |
133,388,621 |
RGD:6480464 |
CTD |
| G |
Bmp3 |
bone morphogenetic protein 3 |
|
affects expression |
ISO |
5 |
99,283,458 |
99,309,979 |
RGD:6480464 |
CTD |
| G |
Bmp8a |
bone morphogenetic protein 8a |
|
increases expression |
ISO |
4 |
122,989,888 |
123,020,046 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects expression |
ISO |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
increases expression |
ISO |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Bptf |
bromodomain PHD finger transcription factor |
|
increases expression |
ISO |
11 |
106,894,395 |
106,993,236 |
RGD:6480464 |
CTD |
| G |
Brap |
BRCA1 associated protein |
|
decreases expression |
ISO |
5 |
122,110,595 |
122,137,257 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1 |
|
increases expression |
ISO |
11 |
101,350,078 |
101,413,269 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2 |
|
increases expression |
ISO |
5 |
151,325,198 |
151,372,324 |
RGD:6480464 |
CTD |
| G |
Brdt |
bromodomain, testis-specific |
|
increases expression |
ISO |
5 |
107,760,213 |
107,816,077 |
RGD:6480464 |
CTD |
| G |
Bub1 |
budding uninhibited by benzimidazoles 1 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
127,625,936 |
127,657,595 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases cleavage |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
EXP |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
EXP |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav2 |
caveolin 2 |
|
decreases expression |
EXP |
6 |
17,231,341 |
17,239,011 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
multiple interactions |
ISO |
16 |
93,608,082 |
93,610,594 |
RGD:6480464 |
CTD |
| G |
Ccl12 |
chemokine (C-C motif) ligand 12 |
|
decreases expression |
ISO |
11 |
81,915,347 |
81,916,901 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases secretion |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
EXP |
11 |
83,461,345 |
83,462,880 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
EXP |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects expression |
EXP |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects phosphorylation |
EXP |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
6 |
127,075,726 |
127,101,066 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
6 |
127,075,726 |
127,101,066 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
17 |
47,642,000 |
47,736,638 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
7 |
38,883,003 |
38,892,509 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
7 |
38,883,003 |
38,892,509 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
4 |
11,118,501 |
11,131,926 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
17 |
24,360,177 |
24,388,354 |
RGD:6480464 |
CTD |
| G |
Cd24a |
CD24a antigen |
|
multiple interactions |
ISO |
10 |
43,298,975 |
43,304,071 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 antigen |
|
multiple interactions |
ISO |
2 |
164,881,136 |
164,897,154 |
RGD:6480464 |
CTD |
| G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
|
decreases expression |
ISO |
18 |
60,963,503 |
60,972,306 |
RGD:6480464 |
CTD |
| G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
|
increases expression |
EXP |
18 |
60,963,503 |
60,972,306 |
RGD:6480464 |
CTD |
| G |
Cd97 |
CD97 antigen |
|
decreases expression |
ISO |
8 |
86,247,150 |
86,265,210 |
RGD:6480464 |
CTD |
| G |
Cdc16 |
CDC16 cell division cycle 16 |
|
decreases expression |
ISO |
8 |
13,757,690 |
13,781,882 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
increases phosphorylation |
ISO |
18 |
34,892,651 |
34,911,187 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
decreases expression |
ISO |
9 |
20,942,985 |
20,954,350 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
multiple interactions |
ISO |
11 |
98,769,203 |
98,785,256 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
11 |
98,769,203 |
98,785,256 |
RGD:6480464 |
CTD |
| G |
Cdc7 |
cell division cycle 7 (S. cerevisiae) |
|
decreases expression |
ISO |
5 |
107,393,341 |
107,413,450 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
increases expression |
ISO |
8 |
105,156,895 |
105,309,011 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
increases expression |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
affects phosphorylation |
EXP |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
affects expression |
EXP |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
10 |
126,500,659 |
126,504,339 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
10 |
126,500,659 |
126,504,339 |
RGD:6480464 |
CTD |
| G |
Cdk8 |
cyclin-dependent kinase 8 |
|
increases expression |
ISO |
5 |
147,043,251 |
147,114,450 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
affects expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases stability |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases methylation |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
increases expression |
ISO |
4 |
109,333,481 |
109,337,977 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
multiple interactions |
ISO |
17 |
34,993,319 |
34,999,459 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
increases expression |
ISO |
19 |
5,490,455 |
5,494,031 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
decreases expression |
ISO |
10 |
127,774,888 |
127,799,535 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
decreases expression |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases secretion |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
increases expression |
EXP |
3 |
157,557,212 |
157,588,027 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases activity |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
EXP |
3 |
95,303,208 |
95,313,284 |
RGD:6480464 |
CTD |
| G |
Ctso |
cathepsin O |
|
multiple interactions |
ISO |
3 |
81,736,538 |
81,760,647 |
RGD:6480464 |
CTD |
| G |
Cul4b |
cullin 4B |
|
increases expression |
ISO |
X |
35,884,793 |
35,929,373 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
5 |
92,775,667 |
92,777,880 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
5 |
92,775,667 |
92,777,880 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
5 |
92,775,667 |
92,777,880 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cyb561d1 |
cytochrome b-561 domain containing 1 |
|
affects expression |
ISO |
3 |
107,998,689 |
108,003,752 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
9,012,378 |
9,046,450 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects expression |
ISO |
6 |
50,512,562 |
50,516,473 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
6 |
50,512,562 |
50,516,473 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases activity |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
|
decreases expression |
EXP |
7 |
27,092,211 |
27,100,107 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
affects expression |
EXP |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2c39 |
cytochrome P450, family 2, subfamily c, polypeptide 39 |
|
increases expression |
EXP |
19 |
39,585,312 |
39,643,019 |
RGD:6480464 |
CTD |
| G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
|
decreases activity |
ISO |
19 |
39,188,388 |
39,261,246 |
RGD:6480464 |
CTD |
| G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
|
multiple interactions |
ISO |
19 |
39,188,388 |
39,261,246 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2j6 |
cytochrome P450, family 2, subfamily j, polypeptide 6 |
|
decreases expression |
EXP |
4 |
96,182,829 |
96,220,342 |
RGD:6480464 |
CTD |
| G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
|
affects expression |
EXP |
5 |
138,334,161 |
138,362,847 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
decreases expression |
EXP |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
decreases activity |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
decreases expression |
EXP |
5 |
4,080,674 |
4,104,697 |
RGD:6480464 |
CTD |
| G |
Dars |
aspartyl-tRNA synthetase |
|
increases expression |
ISO |
1 |
130,260,284 |
130,313,993 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
10 |
126,727,849 |
126,733,344 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
10 |
59,412,423 |
59,414,518 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
affects expression |
ISO |
3 |
137,286,636 |
137,291,296 |
RGD:6480464 |
CTD |
| G |
Defa1 |
defensin, alpha 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Defa2 |
defensin, alpha, 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Denr |
density-regulated protein |
|
increases expression |
ISO |
5 |
124,357,284 |
124,378,841 |
RGD:6480464 |
CTD |
| G |
Derl3 |
Der1-like domain family, member 3 |
|
affects expression |
ISO |
10 |
75,356,143 |
75,358,686 |
RGD:6480464 |
CTD |
| G |
Dgkg |
diacylglycerol kinase, gamma |
|
affects expression |
ISO |
16 |
22,466,641 |
22,657,304 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
increases activity |
ISO |
12 |
91,962,992 |
91,976,878 |
RGD:6480464 |
CTD |
| G |
Dlgap5 |
discs, large (Drosophila) homolog-associated protein 5 |
|
multiple interactions |
ISO |
14 |
48,007,454 |
48,038,082 |
RGD:6480464 |
CTD |
| G |
Dmpk |
dystrophia myotonica-protein kinase |
|
increases expression |
EXP |
7 |
19,669,198 |
19,679,170 |
RGD:6480464 |
CTD |
| G |
Dnase1 |
deoxyribonuclease I |
|
multiple interactions |
ISO |
16 |
4,037,145 |
4,040,024 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
multiple interactions |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
multiple interactions |
ISO |
2 |
62,168,130 |
62,250,288 |
RGD:6480464 |
CTD |
| G |
Dpysl3 |
dihydropyrimidinase-like 3 |
|
increases expression |
ISO |
18 |
43,483,881 |
43,552,985 |
RGD:6480464 |
CTD |
| G |
Drg2 |
developmentally regulated GTP binding protein 2 |
|
decreases expression |
ISO |
11 |
60,268,119 |
60,282,207 |
RGD:6480464 |
CTD |
| G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
|
increases expression |
ISO |
12 |
111,839,605 |
111,905,154 |
RGD:6480464 |
CTD |
| G |
E130016E03Rik |
RIKEN cDNA E130016E03 gene |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
E2f2 |
E2F transcription factor 2 |
|
decreases expression |
ISO |
4 |
135,728,309 |
135,751,972 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
decreases expression |
ISO |
13 |
29,998,444 |
30,077,932 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
|
increases expression |
ISO |
7 |
29,610,357 |
29,617,258 |
RGD:6480464 |
CTD |
| G |
Echdc3 |
enoyl Coenzyme A hydratase domain containing 3 |
|
affects expression |
ISO |
2 |
6,109,511 |
6,134,040 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
ISO |
14 |
104,213,842 |
104,243,390 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
affects expression |
ISO |
14 |
104,213,842 |
104,243,390 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
|
increases expression |
ISO |
11 |
28,753,205 |
28,826,743 |
RGD:6480464 |
CTD |
| G |
EG628438 |
predicted gene, EG628438 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
affects binding |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases expression |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases activity |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
2 |
91,465,477 |
91,476,571 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
multiple interactions |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
decreases expression |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
Fabp6 |
fatty acid binding protein 6, ileal (gastrotropin) |
|
multiple interactions |
ISO |
11 |
43,409,614 |
43,415,013 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
affects localization |
ISO |
7 |
151,764,228 |
151,768,341 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
ISO |
7 |
151,764,228 |
151,768,341 |
RGD:6480464 |
CTD |
| G |
Fam64a |
family with sequence similarity 64, member A |
|
affects expression |
ISO |
11 |
71,856,004 |
71,860,872 |
RGD:6480464 |
CTD |
| G |
Fan1 |
FANCD2/FANCI-associated nuclease 1 |
|
increases expression |
ISO |
7 |
71,491,644 |
71,518,981 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
decreases expression |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fbln2 |
fibulin 2 |
|
increases expression |
ISO |
6 |
91,162,758 |
91,222,534 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose bisphosphatase 1 |
|
decreases expression |
ISO |
13 |
62,966,113 |
62,989,596 |
RGD:6480464 |
CTD |
| G |
Fcgr2b |
Fc receptor, IgG, low affinity IIb |
|
increases expression |
ISO |
1 |
172,890,689 |
172,906,202 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
increases expression |
ISO |
2 |
125,860,394 |
125,916,921 |
RGD:6480464 |
CTD |
| G |
Fgl2 |
fibrinogen-like protein 2 |
|
decreases expression |
ISO |
5 |
20,878,491 |
20,884,204 |
RGD:6480464 |
CTD |
| G |
Fh1 |
fumarate hydratase 1 |
|
increases expression |
ISO |
1 |
177,531,509 |
177,555,766 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
ISO |
1 |
164,759,692 |
164,796,679 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
multiple interactions |
ISO |
3 |
97,432,727 |
97,459,210 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
increases expression |
ISO |
3 |
97,432,727 |
97,459,210 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
affects expression |
ISO |
19 |
5,447,698 |
5,455,938 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
EXP |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Fpr2 |
formyl peptide receptor 2 |
|
increases expression |
ISO |
17 |
18,024,788 |
18,030,916 |
RGD:6480464 |
CTD |
| G |
Fpr3 |
formyl peptide receptor 3 |
|
increases expression |
ISO |
17 |
18,107,422 |
18,108,641 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
11 |
102,465,745 |
102,469,372 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1 switch gene 2 |
|
multiple interactions |
ISO |
1 |
195,098,354 |
195,099,382 |
RGD:6480464 |
CTD |
| G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
multiple interactions |
ISO |
X |
71,654,825 |
71,674,500 |
RGD:6480464 |
CTD |
| G |
Gabpb2 |
GA repeat binding protein, beta 2 |
|
increases expression |
ISO |
3 |
94,985,688 |
95,021,864 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
|
increases expression |
ISO |
10 |
80,392,836 |
80,394,949 |
RGD:6480464 |
CTD |
| G |
Galnt1 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
|
decreases expression |
ISO |
18 |
24,363,845 |
24,445,317 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
EXP |
16 |
42,248,665 |
42,340,764 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
7,536,386 |
7,544,941 |
RGD:6480464 |
CTD |
| G |
Gbe1 |
glucan (1,4-alpha-), branching enzyme 1 |
|
increases expression |
ISO |
16 |
70,314,332 |
70,569,961 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
affects expression |
ISO |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
|
increases expression |
ISO |
3 |
121,948,510 |
121,969,566 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
|
increases expression |
EXP |
3 |
121,948,510 |
121,969,566 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
decreases expression |
ISO |
8 |
73,153,293 |
73,155,534 |
RGD:6480464 |
CTD |
| G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
|
increases expression |
ISO |
8 |
86,176,577 |
86,188,688 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
affects expression |
ISO |
3 |
96,836,339 |
96,857,557 |
RGD:6480464 |
CTD |
| G |
Gldc |
glycine decarboxylase |
|
increases expression |
EXP |
19 |
30,172,937 |
30,249,908 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
increases expression |
ISO |
17 |
30,729,806 |
30,749,604 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 subunit |
|
decreases activity |
ISO |
11 |
55,328,315 |
55,421,292 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 subunit |
|
multiple interactions |
EXP |
11 |
55,328,315 |
55,421,292 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 subunit |
|
multiple interactions |
ISO |
11 |
55,328,315 |
55,421,292 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
ISO |
1 |
52,220,293 |
52,290,076 |
RGD:6480464 |
CTD |
| G |
Gm20117 |
predicted gene, 20117 |
|
increases expression |
ISO |
15 |
79,741,604 |
79,746,338 |
RGD:6480464 |
CTD |
| G |
Gm3776 |
predicted gene 3776 |
|
affects expression |
ISO |
9 |
78,104,936 |
78,116,973 |
RGD:6480464 |
CTD |
| G |
Gm3776 |
predicted gene 3776 |
|
affects expression |
ISO |
9 |
78,104,936 |
78,116,973 |
RGD:6480464 |
CTD |
| G |
Gm6421 |
predicted pseudogene 6421 |
|
decreases acetylation |
ISO |
13 |
118,147,019 |
118,147,429 |
RGD:6480464 |
CTD |
| G |
Gm6421 |
predicted pseudogene 6421 |
|
multiple interactions |
ISO |
13 |
118,147,019 |
118,147,429 |
RGD:6480464 |
CTD |
| G |
Gna15 |
guanine nucleotide binding protein, alpha 15 |
|
increases expression |
ISO |
10 |
80,965,058 |
80,986,970 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
|
affects expression |
ISO |
8 |
96,334,738 |
96,493,288 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
increases expression |
ISO |
11 |
48,613,862 |
48,619,743 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
ISO |
11 |
48,613,862 |
48,619,743 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamate oxaloacetate transaminase 1, soluble |
|
increases expression |
EXP |
19 |
43,574,242 |
43,599,095 |
RGD:6480464 |
CTD |
| G |
Gpi1 |
glucose phosphate isomerase 1 |
|
increases expression |
ISO |
7 |
34,986,346 |
35,015,324 |
RGD:6480464 |
CTD |
| G |
Gpr137b |
G protein-coupled receptor 137B |
|
increases expression |
ISO |
13 |
13,449,887 |
13,485,891 |
RGD:6480464 |
CTD |
| G |
Gpr137b |
G protein-coupled receptor 137B |
|
increases expression |
ISO |
13 |
13,449,887 |
13,485,891 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
multiple interactions |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
decreases expression |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
decreases expression |
EXP |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
decreases expression |
ISO |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
decreases expression |
ISO |
5 |
36,807,834 |
36,816,726 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
decreases expression |
ISO |
7 |
26,013,278 |
26,022,870 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases expression |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
EXP |
2 |
155,388,919 |
155,418,442 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
|
decreases expression |
EXP |
9 |
78,178,827 |
78,194,952 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
affects expression |
ISO |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
increases expression |
ISO |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
decreases expression |
EXP |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
EXP |
6 |
42,195,934 |
42,200,440 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase, mu 3 |
|
decreases expression |
EXP |
3 |
107,766,614 |
107,772,076 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
decreases expression |
EXP |
3 |
107,741,766 |
107,746,667 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
affects expression |
ISO |
10 |
75,236,867 |
75,244,159 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
increases expression |
ISO |
10 |
75,236,867 |
75,244,159 |
RGD:6480464 |
CTD |
| G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
|
increases expression |
EXP |
17 |
34,442,812 |
34,453,619 |
RGD:6480464 |
CTD |
| G |
Higd1a |
HIG1 domain family, member 1A |
|
affects expression |
ISO |
9 |
121,757,678 |
121,767,118 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
multiple interactions |
ISO |
9 |
44,144,431 |
44,152,311 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
EXP |
5 |
149,858,803 |
149,864,613 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
multiple interactions |
ISO |
13 |
97,418,917 |
97,440,891 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
|
increases expression |
ISO |
3 |
98,084,354 |
98,114,661 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
affects expression |
ISO |
15 |
103,070,863 |
103,075,386 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
increases expression |
ISO |
6 |
51,410,433 |
51,419,893 |
RGD:6480464 |
CTD |
| G |
Hnrnph3 |
heterogeneous nuclear ribonucleoprotein H3 |
|
increases expression |
ISO |
10 |
62,477,412 |
62,486,597 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
decreases expression |
ISO |
5 |
100,462,596 |
100,468,241 |
RGD:6480464 |
CTD |
| G |
Hook2 |
hook homolog 2 (Drosophila) |
|
increases expression |
ISO |
8 |
87,514,494 |
87,527,263 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
decreases expression |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
ISO |
8 |
108,042,646 |
108,047,888 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases expression |
EXP |
X |
148,436,439 |
148,438,985 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
multiple interactions |
ISO |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
decreases expression |
EXP |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf2 |
heat shock factor 2 |
|
multiple interactions |
EXP |
10 |
57,206,191 |
57,232,949 |
RGD:6480464 |
CTD |
| G |
Hsf4 |
heat shock transcription factor 4 |
|
multiple interactions |
EXP |
8 |
107,793,774 |
107,799,745 |
RGD:6480464 |
CTD |
| G |
Hsf4 |
heat shock transcription factor 4 |
|
increases expression |
ISO |
8 |
107,793,774 |
107,799,745 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
decreases expression |
ISO |
17 |
45,704,727 |
45,710,210 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
increases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
EXP |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects expression |
EXP |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
decreases expression |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
decreases expression |
EXP |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
multiple interactions |
EXP |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
multiple interactions |
EXP |
11 |
53,073,316 |
53,113,981 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
affects expression |
ISO |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
EXP |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
ISO |
1 |
55,134,678 |
55,144,776 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
1 |
55,144,992 |
55,148,161 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin binding sialoprotein |
|
increases expression |
ISO |
5 |
104,728,306 |
104,740,491 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase |
|
decreases expression |
ISO |
13 |
8,884,852 |
8,891,642 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifngr2 |
interferon gamma receptor 2 |
|
decreases expression |
ISO |
16 |
91,547,339 |
91,564,252 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
multiple interactions |
EXP |
12 |
40,929,716 |
40,949,776 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
increases expression |
EXP |
5 |
77,778,265 |
77,837,070 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappaB kinase beta |
|
multiple interactions |
EXP |
8 |
23,769,677 |
23,817,055 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
affects expression |
ISO |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
2 |
129,125,346 |
129,135,708 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
ISO |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Iqcf1 |
IQ motif containing F1 |
|
increases expression |
ISO |
9 |
106,402,298 |
106,404,581 |
RGD:6480464 |
CTD |
| G |
Irf3 |
interferon regulatory factor 3 |
|
multiple interactions |
EXP |
7 |
52,253,030 |
52,258,218 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin alpha 6 |
|
increases expression |
ISO |
2 |
71,625,140 |
71,694,815 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin beta 2 |
|
multiple interactions |
ISO |
10 |
76,993,093 |
77,028,419 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
affects localization |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
decreases activity |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jund |
Jun proto-oncogene related gene d |
|
multiple interactions |
ISO |
8 |
73,221,638 |
73,224,515 |
RGD:6480464 |
CTD |
| G |
Kdm5a |
lysine (K)-specific demethylase 5A |
|
affects expression |
ISO |
6 |
120,314,117 |
120,394,592 |
RGD:6480464 |
CTD |
| G |
Keap1 |
kelch-like ECH-associated protein 1 |
|
multiple interactions |
ISO |
9 |
21,034,174 |
21,043,776 |
RGD:6480464 |
CTD |
| G |
Kif15 |
kinesin family member 15 |
|
decreases expression |
ISO |
9 |
122,860,199 |
122,927,851 |
RGD:6480464 |
CTD |
| G |
Kif20b |
kinesin family member 20B |
|
decreases expression |
ISO |
19 |
34,996,848 |
35,050,221 |
RGD:6480464 |
CTD |
| G |
Kif23 |
kinesin family member 23 |
|
multiple interactions |
ISO |
9 |
61,765,084 |
61,794,606 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
increases expression |
ISO |
17 |
34,012,611 |
34,027,600 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
increases expression |
ISO |
17 |
34,012,611 |
34,027,600 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
multiple interactions |
EXP |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Klc4 |
kinesin light chain 4 |
|
increases expression |
ISO |
17 |
46,767,580 |
46,782,093 |
RGD:6480464 |
CTD |
| G |
Klf15 |
Kruppel-like factor 15 |
|
affects expression |
ISO |
6 |
90,412,620 |
90,425,203 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
decreases expression |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
increases expression |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
6 |
145,165,219 |
145,198,751 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
6 |
145,165,219 |
145,198,751 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
15 |
101,675,857 |
101,681,217 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
multiple interactions |
EXP |
15 |
101,675,857 |
101,681,217 |
RGD:6480464 |
CTD |
| G |
Krt20 |
keratin 20 |
|
increases expression |
ISO |
11 |
99,289,717 |
99,299,467 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases expression |
ISO |
15 |
101,827,142 |
101,834,773 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
multiple interactions |
ISO |
8 |
108,463,451 |
108,467,302 |
RGD:6480464 |
CTD |
| G |
Ldb2 |
LIM domain binding 2 |
|
affects expression |
ISO |
5 |
44,863,372 |
45,190,946 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
affects expression |
ISO |
3 |
130,813,389 |
130,926,252 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
decreases expression |
ISO |
3 |
130,813,389 |
130,926,252 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactose binding, soluble 1 |
|
multiple interactions |
ISO |
15 |
78,757,155 |
78,760,895 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
decreases expression |
ISO |
11 |
118,254,066 |
118,263,245 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A |
|
decreases expression |
ISO |
3 |
88,285,071 |
88,307,254 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
decreases expression |
ISO |
18 |
56,867,467 |
56,913,078 |
RGD:6480464 |
CTD |
| G |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 |
|
decreases expression |
ISO |
6 |
66,485,462 |
66,490,985 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
|
multiple interactions |
ISO |
15 |
79,178,108 |
79,189,506 |
RGD:6480464 |
CTD |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
multiple interactions |
ISO |
18 |
65,590,651 |
65,638,446 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
|
decreases expression |
ISO |
11 |
65,501,746 |
65,601,799 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
|
increases expression |
ISO |
11 |
65,501,746 |
65,601,799 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen-activated protein kinase kinase kinase 12 |
|
decreases expression |
ISO |
15 |
102,328,078 |
102,347,435 |
RGD:6480464 |
CTD |
| G |
Map4k1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
|
decreases expression |
ISO |
7 |
29,767,873 |
29,788,298 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases expression |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
affects phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen-activated protein kinase 10 |
|
multiple interactions |
EXP |
5 |
103,336,967 |
103,640,353 |
RGD:6480464 |
CTD |
| G |
Mapk13 |
mitogen-activated protein kinase 13 |
|
affects expression |
ISO |
17 |
28,906,262 |
28,915,649 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases expression |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases expression |
ISO |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
affects expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
affects expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Muc2 |
mucin 2 |
|
increases expression |
ISO |
7 |
148,876,261 |
148,890,250 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
multiple interactions |
ISO |
7 |
148,974,916 |
149,005,040 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
increases expression |
ISO |
4 |
116,480,339 |
116,492,036 |
RGD:6480464 |
CTD |
| G |
Myb |
myeloblastosis oncogene |
|
decreases expression |
ISO |
10 |
20,844,736 |
20,880,790 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
multiple interactions |
ISO |
2 |
162,880,371 |
162,910,423 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response gene 88 |
|
decreases expression |
ISO |
9 |
119,245,106 |
119,249,158 |
RGD:6480464 |
CTD |
| G |
Myo1a |
myosin IA |
|
multiple interactions |
ISO |
10 |
127,142,312 |
127,157,996 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases expression |
ISO |
9 |
74,919,013 |
75,071,495 |
RGD:6480464 |
CTD |
| G |
Myo5c |
myosin VC |
|
decreases expression |
ISO |
9 |
75,079,821 |
75,153,258 |
RGD:6480464 |
CTD |
| G |
Myo5c |
myosin VC |
|
decreases expression |
ISO |
9 |
75,079,821 |
75,153,258 |
RGD:6480464 |
CTD |
| G |
Naa15 |
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
|
decreases expression |
ISO |
3 |
51,219,938 |
51,279,907 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
decreases expression |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated gene 1 |
|
increases expression |
ISO |
15 |
66,760,880 |
66,801,203 |
RGD:6480464 |
CTD |
| G |
Ndufa4 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 |
|
decreases expression |
ISO |
6 |
11,850,373 |
11,857,446 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
decreases expression |
ISO |
1 |
63,190,166 |
63,223,396 |
RGD:6480464 |
CTD |
| G |
Nedd8 |
neural precursor cell expressed, developmentally down-regulated gene 8 |
|
increases expression |
ISO |
14 |
56,281,104 |
56,290,743 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
affects expression |
ISO |
3 |
87,775,015 |
87,784,373 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
multiple interactions |
ISO |
15 |
103,078,648 |
103,085,847 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects response to substance |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
EXP |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
decreases phosphorylation |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
EXP |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
EXP |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
EXP |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfya |
nuclear transcription factor-Y alpha |
|
multiple interactions |
ISO |
17 |
48,526,210 |
48,549,145 |
RGD:6480464 |
CTD |
| G |
Nin |
ninein |
|
decreases expression |
ISO |
12 |
71,112,422 |
71,212,912 |
RGD:6480464 |
CTD |
| G |
Nkx3-1 |
NK-3 transcription factor, locus 1 (Drosophila) |
|
decreases expression |
ISO |
14 |
69,808,749 |
69,812,715 |
RGD:6480464 |
CTD |
| G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
|
decreases expression |
ISO |
17 |
26,228,690 |
26,232,415 |
RGD:6480464 |
CTD |
| G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
|
decreases expression |
ISO |
17 |
26,228,690 |
26,232,415 |
RGD:6480464 |
CTD |
| G |
Nme6 |
NME/NM23 nucleoside diphosphate kinase 6 |
|
decreases expression |
ISO |
9 |
109,735,308 |
109,745,475 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
affects expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide type B |
|
affects expression |
ISO |
4 |
147,359,898 |
147,361,314 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
affects expression |
ISO |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
affects binding |
ISO |
13 |
34,056,528 |
34,080,334 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
increases expression |
ISO |
11 |
98,629,249 |
98,636,556 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
16 |
38,248,435 |
38,294,910 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases activity |
ISO |
1 |
173,144,101 |
173,148,975 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects activity |
EXP |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet derived growth factor, B polypeptide |
|
multiple interactions |
ISO |
15 |
79,826,304 |
79,845,238 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
increases expression |
ISO |
X |
103,382,463 |
103,399,038 |
RGD:6480464 |
CTD |
| G |
Phf10 |
PHD finger protein 10 |
|
decreases expression |
ISO |
17 |
15,081,999 |
15,098,237 |
RGD:6480464 |
CTD |
| G |
Pin1 |
protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 |
|
decreases expression |
ISO |
9 |
20,456,574 |
20,471,028 |
RGD:6480464 |
CTD |
| G |
Pitx2 |
paired-like homeodomain transcription factor 2 |
|
increases expression |
ISO |
3 |
128,902,836 |
128,922,509 |
RGD:6480464 |
CTD |
| G |
Pja2 |
praja 2, RING-H2 motif containing |
|
increases expression |
ISO |
17 |
64,630,355 |
64,681,223 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
decreases expression |
ISO |
9 |
59,504,415 |
59,527,182 |
RGD:6480464 |
CTD |
| G |
Pkp2 |
plakophilin 2 |
|
decreases expression |
ISO |
16 |
16,213,438 |
16,272,805 |
RGD:6480464 |
CTD |
| G |
Pla2g16 |
phospholipase A2, group XVI |
|
multiple interactions |
ISO |
19 |
7,631,949 |
7,663,035 |
RGD:6480464 |
CTD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
affects expression |
ISO |
17 |
43,705,400 |
43,749,150 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases secretion |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
multiple interactions |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plcd3 |
phospholipase C, delta 3 |
|
decreases expression |
ISO |
11 |
102,931,610 |
102,962,972 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
multiple interactions |
ISO |
7 |
129,302,951 |
129,313,389 |
RGD:6480464 |
CTD |
| G |
Pnkp |
polynucleotide kinase 3'- phosphatase |
|
increases expression |
ISO |
7 |
52,112,551 |
52,118,299 |
RGD:6480464 |
CTD |
| G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
decreases expression |
EXP |
15 |
83,998,246 |
84,019,951 |
RGD:6480464 |
CTD |
| G |
Pola1 |
polymerase (DNA directed), alpha 1 |
|
decreases expression |
ISO |
X |
90,550,105 |
90,877,494 |
RGD:6480464 |
CTD |
| G |
Pold2 |
polymerase (DNA directed), delta 2, regulatory subunit |
|
decreases expression |
ISO |
11 |
5,772,183 |
5,778,259 |
RGD:6480464 |
CTD |
| G |
Poldip2 |
polymerase (DNA-directed), delta interacting protein 2 |
|
increases expression |
ISO |
11 |
78,325,798 |
78,336,238 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
multiple interactions |
ISO |
6 |
5,118,090 |
5,143,946 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases activity |
ISO |
6 |
5,118,090 |
5,143,946 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases expression |
ISO |
6 |
5,118,090 |
5,143,946 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases expression |
ISO |
6 |
5,118,090 |
5,143,946 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases activity |
ISO |
6 |
5,118,090 |
5,143,946 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
decreases activity |
ISO |
5 |
136,165,084 |
136,211,195 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases activity |
ISO |
5 |
136,165,084 |
136,211,195 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator activator receptor delta |
|
multiple interactions |
ISO |
17 |
28,369,699 |
28,438,414 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
increases expression |
EXP |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppia |
peptidylprolyl isomerase A |
|
increases expression |
ISO |
11 |
6,315,873 |
6,319,813 |
RGD:6480464 |
CTD |
| G |
Ppil4 |
peptidylprolyl isomerase (cyclophilin)-like 4 |
|
affects expression |
ISO |
10 |
7,512,692 |
7,542,361 |
RGD:6480464 |
CTD |
| G |
Ppp1r1a |
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
|
decreases expression |
ISO |
15 |
103,360,710 |
103,368,423 |
RGD:6480464 |
CTD |
| G |
Ppp2r4 |
protein phosphatase 2A, regulatory subunit B (PR 53) |
|
decreases expression |
ISO |
2 |
30,271,570 |
30,303,327 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
4 |
116,358,204 |
116,372,605 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
multiple interactions |
ISO |
8 |
87,493,547 |
87,498,212 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
ISO |
8 |
87,493,547 |
87,498,212 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
increases expression |
ISO |
X |
151,758,463 |
151,772,997 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
increases expression |
ISO |
1 |
163,170,243 |
163,181,297 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
14 |
31,408,555 |
31,423,498 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
14 |
31,408,555 |
31,423,498 |
RGD:6480464 |
CTD |
| G |
Prkcq |
protein kinase C, theta |
|
increases expression |
ISO |
2 |
11,094,009 |
11,222,853 |
RGD:6480464 |
CTD |
| G |
Psca |
prostate stem cell antigen |
|
decreases expression |
ISO |
15 |
74,545,269 |
74,547,495 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Ptgfrn |
prostaglandin F2 receptor negative regulator |
|
increases expression |
ISO |
3 |
100,844,159 |
100,914,089 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
affects expression |
ISO |
4 |
58,978,462 |
58,999,950 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
decreases activity |
ISO |
4 |
58,978,462 |
58,999,950 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
2 |
36,085,946 |
36,107,789 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases expression |
ISO |
2 |
36,085,946 |
36,107,789 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases activity |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases activity |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
decreases phosphorylation |
ISO |
15 |
73,035,535 |
73,253,621 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
multiple interactions |
ISO |
15 |
73,035,535 |
73,253,621 |
RGD:6480464 |
CTD |
| G |
Rab3b |
RAB3B, member RAS oncogene family |
|
multiple interactions |
ISO |
4 |
108,551,675 |
108,615,929 |
RGD:6480464 |
CTD |
| G |
Rala |
v-ral simian leukemia viral oncogene homolog A (ras related) |
|
decreases expression |
ISO |
13 |
17,972,409 |
18,036,051 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
decreases expression |
ISO |
14 |
17,263,353 |
17,407,724 |
RGD:6480464 |
CTD |
| G |
Rasgrp3 |
RAS, guanyl releasing protein 3 |
|
affects expression |
ISO |
17 |
75,835,245 |
75,928,394 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
affects expression |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases expression |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif protein 3 |
|
decreases expression |
ISO |
X |
7,716,101 |
7,722,928 |
RGD:6480464 |
CTD |
| G |
Rbm4 |
RNA binding motif protein 4 |
|
decreases expression |
ISO |
19 |
4,784,293 |
4,793,877 |
RGD:6480464 |
CTD |
| G |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
|
decreases expression |
ISO |
2 |
60,590,010 |
60,801,261 |
RGD:6480464 |
CTD |
| G |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
|
decreases expression |
ISO |
10 |
127,566,526 |
127,617,353 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin, platelet |
|
multiple interactions |
ISO |
1 |
166,045,509 |
166,079,876 |
RGD:6480464 |
CTD |
| G |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
|
decreases expression |
ISO |
5 |
17,080,634 |
17,236,086 |
RGD:6480464 |
CTD |
| G |
Serpinb3d |
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3D |
|
increases expression |
ISO |
1 |
108,974,770 |
108,980,057 |
RGD:6480464 |
CTD |
| G |
Serpinb9 |
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
|
increases expression |
ISO |
13 |
33,096,410 |
33,109,824 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
multiple interactions |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
decreases expression |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases expression |
ISO |
4 |
133,156,471 |
133,158,083 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
decreases expression |
ISO |
8 |
24,521,974 |
24,560,104 |
RGD:6480464 |
CTD |
| G |
Sh3bp2 |
SH3-domain binding protein 2 |
|
increases expression |
ISO |
5 |
34,868,433 |
34,906,288 |
RGD:6480464 |
CTD |
| G |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
|
increases expression |
EXP |
11 |
60,602,399 |
60,624,767 |
RGD:6480464 |
CTD |
| G |
Siah1a |
seven in absentia 1A |
|
decreases expression |
ISO |
8 |
89,247,832 |
89,269,905 |
RGD:6480464 |
CTD |
| G |
Siah2 |
seven in absentia 2 |
|
decreases expression |
ISO |
3 |
58,478,871 |
58,496,310 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
increases expression |
EXP |
10 |
62,781,753 |
62,801,783 |
RGD:6480464 |
CTD |
| G |
Sis |
sucrase isomaltase (alpha-glucosidase) |
|
multiple interactions |
ISO |
3 |
72,692,482 |
72,770,788 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
|
multiple interactions |
ISO |
3 |
104,442,591 |
104,462,385 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
|
multiple interactions |
ISO |
3 |
104,442,591 |
104,462,385 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
|
affects expression |
ISO |
11 |
120,809,798 |
120,820,314 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (organic cation transporter), member 3 |
|
increases expression |
ISO |
17 |
12,612,838 |
12,700,570 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
multiple interactions |
ISO |
18 |
35,774,258 |
35,786,881 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
multiple interactions |
ISO |
2 |
131,878,232 |
131,970,844 |
RGD:6480464 |
CTD |
| G |
Slc25a5 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 |
|
decreases expression |
ISO |
X |
34,335,647 |
34,338,801 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions |
ISO |
4 |
118,781,350 |
118,809,935 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases activity |
ISO |
4 |
118,781,350 |
118,809,935 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases activity |
ISO |
3 |
28,596,825 |
28,627,283 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
affects expression |
ISO |
8 |
73,406,788 |
73,416,656 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
8 |
73,406,788 |
73,416,656 |
RGD:6480464 |
CTD |
| G |
Smad5 |
SMAD family member 5 |
|
decreases expression |
ISO |
13 |
56,804,371 |
56,843,739 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha |
|
multiple interactions |
ISO |
6 |
60,681,567 |
60,779,849 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects expression |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
increases expression |
ISO |
19 |
40,366,530 |
40,588,302 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
decreases expression |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
increases activity |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Srrm1 |
serine/arginine repetitive matrix 1 |
|
affects expression |
ISO |
4 |
134,876,399 |
134,909,129 |
RGD:6480464 |
CTD |
| G |
Srsf6 |
serine/arginine-rich splicing factor 6 |
|
affects expression |
ISO |
2 |
162,757,244 |
162,762,857 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
|
affects expression |
ISO |
2 |
151,931,466 |
151,937,089 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
8 |
26,918,985 |
26,926,454 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
8 |
26,918,985 |
26,926,454 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
decreases expression |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
decreases phosphorylation |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
EXP |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
EXP |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat2 |
signal transducer and activator of transcription 2 |
|
multiple interactions |
ISO |
10 |
127,707,632 |
127,729,905 |
RGD:6480464 |
CTD |
| G |
Stc1 |
stanniocalcin 1 |
|
increases expression |
ISO |
14 |
69,647,346 |
69,659,458 |
RGD:6480464 |
CTD |
| G |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
|
multiple interactions |
ISO |
1 |
53,812,356 |
53,842,059 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
decreases expression |
ISO |
4 |
134,024,235 |
134,029,758 |
RGD:6480464 |
CTD |
| G |
Strn4 |
striatin, calmodulin binding protein 4 |
|
affects expression |
ISO |
7 |
17,401,238 |
17,426,280 |
RGD:6480464 |
CTD |
| G |
Sub1 |
SUB1 homolog (S. cerevisiae) |
|
increases expression |
ISO |
15 |
11,911,094 |
11,925,762 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
increases sulfation |
ISO |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family 1B, member 1 |
|
affects expression |
EXP |
5 |
87,942,364 |
87,967,220 |
RGD:6480464 |
CTD |
| G |
Sult1c1 |
sulfotransferase family, cytosolic, 1C, member 1 |
|
multiple interactions |
ISO |
17 |
54,100,940 |
54,129,956 |
RGD:6480464 |
CTD |
| G |
Sult1c1 |
sulfotransferase family, cytosolic, 1C, member 1 |
|
multiple interactions |
ISO |
17 |
54,100,940 |
54,129,956 |
RGD:6480464 |
CTD |
| G |
Sult1d1 |
sulfotransferase family 1D, member 1 |
|
affects expression |
EXP |
5 |
87,983,675 |
87,998,031 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, member 1 |
|
multiple interactions |
ISO |
5 |
88,004,993 |
88,020,636 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, member 1 |
|
multiple interactions |
ISO |
5 |
88,004,993 |
88,020,636 |
RGD:6480464 |
CTD |
| G |
Taf9 |
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
increases expression |
ISO |
13 |
101,421,298 |
101,436,368 |
RGD:6480464 |
CTD |
| G |
Tagln2 |
transgelin 2 |
|
decreases expression |
ISO |
1 |
174,430,377 |
174,437,506 |
RGD:6480464 |
CTD |
| G |
Tbk1 |
TANK-binding kinase 1 |
|
decreases activity |
ISO |
10 |
120,983,511 |
121,023,850 |
RGD:6480464 |
CTD |
| G |
Tceb2 |
transcription elongation factor B (SIII), polypeptide 2 |
|
decreases expression |
ISO |
17 |
23,961,707 |
23,966,076 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
multiple interactions |
ISO |
18 |
69,504,146 |
69,847,621 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
affects expression |
ISO |
18 |
69,504,146 |
69,847,621 |
RGD:6480464 |
CTD |
| G |
Tcf7 |
transcription factor 7, T cell specific |
|
decreases expression |
ISO |
11 |
52,066,106 |
52,096,073 |
RGD:6480464 |
CTD |
| G |
Tcte1 |
t-complex-associated testis expressed 1 |
|
decreases expression |
ISO |
17 |
45,660,383 |
45,679,628 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 (spasmolytic protein 1) |
|
multiple interactions |
ISO |
17 |
31,278,007 |
31,281,227 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
affects expression |
ISO |
6 |
3,912,595 |
3,918,354 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
14 |
70,167,279 |
70,184,218 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
14 |
70,167,279 |
70,184,218 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
affects localization |
ISO |
14 |
70,167,279 |
70,184,218 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
14 |
70,167,279 |
70,184,218 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a |
|
multiple interactions |
EXP |
1 |
107,677,300 |
107,744,558 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
increases expression |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
increases expression |
ISO |
4 |
144,802,271 |
144,836,773 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases activity |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnnc1 |
troponin C, cardiac/slow skeletal |
|
decreases expression |
ISO |
14 |
32,021,498 |
32,024,897 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
increases expression |
ISO |
6 |
124,760,610 |
124,764,314 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
decreases expression |
ISO |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Tradd |
TNFRSF1A-associated via death domain |
|
multiple interactions |
ISO |
8 |
107,782,475 |
107,788,494 |
RGD:6480464 |
CTD |
| G |
Trf |
transferrin |
|
multiple interactions |
ISO |
9 |
103,111,206 |
103,132,616 |
RGD:6480464 |
CTD |
| G |
Trf |
transferrin |
|
multiple interactions |
ISO |
9 |
103,111,206 |
103,132,616 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
multiple interactions |
ISO |
2 |
152,163,161 |
152,169,796 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
decreases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
decreases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
affects localization |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53bp2 |
transformation related protein 53 binding protein 2 |
|
increases expression |
ISO |
1 |
184,339,298 |
184,392,567 |
RGD:6480464 |
CTD |
| G |
Trp63 |
transformation related protein 63 |
|
increases expression |
ISO |
16 |
25,683,851 |
25,892,174 |
RGD:6480464 |
CTD |
| G |
Trp73 |
transformation related protein 73 |
|
increases expression |
ISO |
4 |
153,430,358 |
153,514,317 |
RGD:6480464 |
CTD |
| G |
Tsc1 |
tuberous sclerosis 1 |
|
increases expression |
ISO |
2 |
28,496,763 |
28,546,687 |
RGD:6480464 |
CTD |
| G |
Tsc2 |
tuberous sclerosis 2 |
|
increases expression |
ISO |
17 |
24,732,882 |
24,769,574 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
decreases expression |
ISO |
X |
137,074,067 |
137,135,061 |
RGD:6480464 |
CTD |
| G |
Tsfm |
Ts translation elongation factor, mitochondrial |
|
increases expression |
ISO |
10 |
126,459,388 |
126,467,870 |
RGD:6480464 |
CTD |
| G |
Tsfm |
Ts translation elongation factor, mitochondrial |
|
increases expression |
ISO |
10 |
126,459,388 |
126,467,870 |
RGD:6480464 |
CTD |
| G |
Tsg101 |
tumor susceptibility gene 101 |
|
increases expression |
ISO |
7 |
54,144,397 |
54,175,300 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta subunit |
|
multiple interactions |
ISO |
3 |
102,581,321 |
102,586,637 |
RGD:6480464 |
CTD |
| G |
Tspan3 |
tetraspanin 3 |
|
decreases expression |
ISO |
9 |
55,983,691 |
56,008,877 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
decreases expression |
ISO |
15 |
98,780,278 |
98,783,932 |
RGD:6480464 |
CTD |
| G |
Tuba1c |
tubulin, alpha 1C |
|
decreases expression |
ISO |
15 |
98,860,322 |
98,868,536 |
RGD:6480464 |
CTD |
| G |
Tuba8 |
tubulin, alpha 8 |
|
decreases expression |
ISO |
6 |
121,160,788 |
121,176,115 |
RGD:6480464 |
CTD |
| G |
Tufm |
Tu translation elongation factor, mitochondrial |
|
increases expression |
ISO |
7 |
133,630,869 |
133,634,245 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
affects expression |
ISO |
10 |
82,296,696 |
82,360,469 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
multiple interactions |
ISO |
7 |
94,575,915 |
94,641,921 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases activity |
ISO |
7 |
94,575,915 |
94,641,921 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases metabolic processing |
ISO |
7 |
94,575,915 |
94,641,921 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases response to substance |
ISO |
7 |
94,575,915 |
94,641,921 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
decreases expression |
ISO |
11 |
62,365,006 |
62,366,714 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
decreases expression |
EXP |
5 |
125,866,335 |
125,870,387 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
7 |
107,621,500 |
107,634,941 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose dehydrogenase |
|
decreases expression |
ISO |
5 |
65,804,460 |
65,827,081 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
multiple interactions |
ISO |
1 |
90,108,534 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
1 |
90,108,534 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases glucuronidation |
ISO |
1 |
90,108,534 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
affects glucuronidation |
ISO |
1 |
90,097,186 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases glucuronidation |
ISO |
1 |
90,097,186 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a6a |
UDP glucuronosyltransferase 1 family, polypeptide A6A |
|
increases expression |
ISO |
1 |
90,031,384 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases glucuronidation |
ISO |
1 |
89,967,354 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
multiple interactions |
ISO |
1 |
89,967,354 |
90,116,577 |
RGD:6480464 |
CTD |
| G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
|
multiple interactions |
ISO |
5 |
87,429,885 |
87,442,299 |
RGD:6480464 |
CTD |
| G |
Ugt2b38 |
UDP glucuronosyltransferase 2 family, polypeptide B38 |
|
multiple interactions |
ISO |
5 |
87,838,964 |
87,853,228 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
affects expression |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
ISO |
11 |
52,174,617 |
52,202,898 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases secretion |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
multiple interactions |
ISO |
6 |
113,574,015 |
113,581,627 |
RGD:6480464 |
CTD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
increases expression |
ISO |
6 |
113,574,015 |
113,581,627 |
RGD:6480464 |
CTD |
| G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
|
increases expression |
ISO |
9 |
121,551,834 |
121,582,072 |
RGD:6480464 |
CTD |
| G |
Vps39 |
vacuolar protein sorting 39 (yeast) |
|
increases expression |
ISO |
2 |
120,142,197 |
120,178,869 |
RGD:6480464 |
CTD |
| G |
Vrk2 |
vaccinia related kinase 2 |
|
decreases expression |
ISO |
11 |
26,371,401 |
26,493,920 |
RGD:6480464 |
CTD |
| G |
Wash |
WAS protein family homolog |
|
increases expression |
ISO |
17 |
66,460,886 |
66,469,843 |
RGD:6480464 |
CTD |
| G |
Wee1 |
WEE 1 homolog 1 (S. pombe) |
|
increases expression |
ISO |
7 |
117,265,573 |
117,286,813 |
RGD:6480464 |
CTD |
| G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
|
increases expression |
ISO |
11 |
79,052,884 |
79,068,197 |
RGD:6480464 |
CTD |
| G |
Wwtr1 |
WW domain containing transcription regulator 1 |
|
multiple interactions |
ISO |
3 |
57,259,566 |
57,379,832 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
multiple interactions |
ISO |
11 |
5,420,970 |
5,425,875 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases splicing |
ISO |
11 |
5,420,970 |
5,425,875 |
RGD:6480464 |
CTD |
| G |
Xpc |
xeroderma pigmentosum, complementation group C |
|
increases expression |
ISO |
6 |
91,439,299 |
91,465,882 |
RGD:6480464 |
CTD |
| G |
Xpnpep2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
|
multiple interactions |
ISO |
X |
45,461,902 |
45,490,158 |
RGD:6480464 |
CTD |
| G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
decreases expression |
ISO |
11 |
75,546,389 |
75,579,343 |
RGD:6480464 |
CTD |
| G |
Zbtb14 |
zinc finger and BTB domain containing 14 |
|
decreases expression |
ISO |
17 |
69,733,318 |
69,739,884 |
RGD:6480464 |
CTD |
| G |
Zc3h6 |
zinc finger CCCH type containing 6 |
|
affects expression |
ISO |
2 |
128,793,138 |
128,844,299 |
RGD:6480464 |
CTD |
| G |
Zfp26 |
zinc finger protein 26 |
|
increases expression |
ISO |
9 |
20,232,762 |
20,264,604 |
RGD:6480464 |
CTD |
| G |
Zfp708 |
zinc finger protein 708 |
|
decreases expression |
ISO |
13 |
67,170,334 |
67,198,912 |
RGD:6480464 |
CTD |
| G |
Zw10 |
zw10 kinetochore protein |
|
decreases expression |
ISO |
9 |
48,863,737 |
48,886,878 |
RGD:6480464 |
CTD |
Term paths to the root
| Path 1 |
CHEBI ontology |
500591 |
 |
role |
490275 |
 |
chemical role |
211777 |
 |
| antioxidant |
26560 |
 |
quercetin |
4412 |
 |
| 3',4',5,7-tetrahydroxy-3-methoxyflavone |
0 |
 |
| 3',4',5-trihydroxy-3,7-dimethoxyflavone |
0 |
 |
| 3',5-dihydroxy-3,4',7-trimethoxyflavone |
0 |
 |
| cis-dihydroquercetin |
0 |
 |
| cudranian 2 |
0 |
 |
| isorhamnetin + |
12 |
 |
| quercetagetin + |
1 |
 |
| quercetin 3,4'-dimethyl ether |
0 |
 |
| quercetin O-glucoside + |
116 |
 |
| quercetin sulfate + |
0 |
 |
| tamarixetin |
0 |
 |
| Path 2 |
CHEBI ontology |
500591 |
 |
subatomic particle |
499508 |
 |
composite particle |
499508 |
 |
hadron |
499508 |
 |
baryon |
499508 |
 |
nucleon |
499508 |
 |
atomic nucleus |
499508 |
 |
atom |
499508 |
 |
main group element atom |
468781 |
 |
p-block element atom |
466276 |
 |
carbon group element atom |
417557 |
 |
carbon atom |
414040 |
 |
organic molecular entity |
414034 |
 |
organic molecule |
365852 |
 |
organic cyclic compound |
303674 |
 |
organic heterocyclic compound |
156584 |
 |
oxacycle |
53956 |
 |
benzopyran |
18884 |
 |
| 1-benzopyran |
18001 |
 |
flavonoid |
8111 |
 |
flavones |
5494 |
 |
hydroxyflavone |
5463 |
 |
flavonols |
4850 |
 |
7-hydroxyflavonol |
4573 |
 |
quercetin |
4412 |
 |
| 3',4',5,7-tetrahydroxy-3-methoxyflavone |
0 |
 |
| 3',4',5-trihydroxy-3,7-dimethoxyflavone |
0 |
 |
| 3',5-dihydroxy-3,4',7-trimethoxyflavone |
0 |
 |
| cis-dihydroquercetin |
0 |
 |
| cudranian 2 |
0 |
 |
| isorhamnetin + |
12 |
 |
| quercetagetin + |
1 |
 |
| quercetin 3,4'-dimethyl ether |
0 |
 |
| quercetin O-glucoside + |
116 |
| |
|